Milton C. Weinstein
Milton C. Weinstein, Ph.D., is the Henry J. Kaiser Professor of Health Policy and Management at the Harvard School of Public Health, Professor of Medicine at the Harvard Medical School, Director of the Program on Economic Evaluation of Medical Technology, and Academic Director of the Program in Health Decision Science. He is best known for his research on cost-effectiveness of medical practices and for developing methods of economic evaluation and decision analysis in health care. He is a co-developer of the CEPAC (Cost-Effectiveness of Preventing AIDS Complications) computer simulation model and has conducted studies on preventing and treating HIV infections. He is also the co-developer of the Coronary Heart Disease Policy Model, which has been used to evaluate the cost-effectiveness of cardiovascular prevention and treatment. Dr. Weinstein is currently involved in research projects relating to testing and treatment for HIV/AIDS and tuberculosis, screening for lung cancer, and treating cardiovascular risk factors in the U.S. and developing countries. He was a member of both Institute of Medicine Committees on Vaccine Priorities and developed the methodology that was used in both of their reports to quantify the potential health and economic benefits of new vaccines. He has published more than 200 papers in peer-reviewed medical, public health, and economics journals and is an elected member of the Institute of Medicine of the National Academy of Sciences as well as a recipient of the Award for Career Achievement from the Society for Medical Decision Making. Dr. Weinstein received his A.B. and A.M. in Applied Mathematics (1970), his M.P.P. (1972), and his Ph.D. in Public Policy (1973), all from Harvard University.